Clinical Trials Browser

1-methyltryptophan × Dermatologic × Clear all

NCT03301636 2022-09-27

NLG2107

Phase 2 Terminated

21 enrolled 11 charts

Melanoma

NCT02073123 2020-06-05

Study of IDO Inhibitor in Combination With Checkpoint Inhibitors for Adult Patients With Metastatic Melanoma

Phase 1/2 Completed

Melanoma

NCT00739609 2020-05-28

D-1MT

Phase 1 Terminated

BreastDermatologicGastrointestinalThoracic

Breast Neoplasms, Lung Neoplasms, Melanoma, Pancreatic Neoplasms